NYSE · Medical - Instruments & Supplies

Alcon Inc. (ALC) Stock

$70.17 -0.65% NYSE: ALC Healthcare

Valuation

MetricValue
Price$70.17
Market Cap$33.92B
P/E Ratio50.34
P/B Ratio1.47
P/S Ratio2.95
EPS (TTM)$1.98
52-Week High$87.64
52-Week Low$61.84
Dividend Yield0.55%

Financials & Margins

MetricValue
ROE2.91%
ROA2.06%
ROCE3.82%
Gross Margin24.53%
Operating Margin13.08%
Net Margin5.92%
Debt/Equity0.25
Current Ratio2.12

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.3B$8.7B$9.5B$9.9B$10.4B
Operating Profit$580.0M$672.0M$1.0B$1.4B$1.4B
Net Profit$376.0M$335.0M$974.0M$1.0B$980.0M
EPS$0.76$0.68$1.96$2.05$1.98
Op Margin7.0%7.7%11.0%14.3%13.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$28.0B$29.2B$29.6B$30.3B$31.6B
Total Liabilities$8.7B$9.5B$9.0B$8.8B$9.5B
Cash$1.6B$980.0M$1.1B$1.7B$1.5B
Borrowings$4.5B$5.1B$5.1B$5.1B$5.2B

Latest News

IART Stock Surges 52.1% in a Year: What's Driving the Rally? Zacks · Jul 15, 2026 Will Zimmer Biomet’s New Asia Pacific Leader Reframe Its Robotics-Led Growth Story (ZBH)? Simply Wall St. · Jul 15, 2026 Thermo Fisher Set to Report Q2 Earnings: What's in the Cards? Zacks · Jul 15, 2026 Mexican Gold Mining Corp. to Effect Share Consolidation and Name Change and Announces Closing of $2,299,000 Subscription Receipt Financing TMX Newsfile · Jul 14, 2026 Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.3B$1.2B$1.4B$2.1B$2.3B
Investing Cash Flow$-2.4B$-2.6B$-1.9B$-1.8B$-2.0B
Financing Cash Flow$-6.0M$-113.0M$-88.0M$-55.0M$-857.0M
Net Cash Flow$18.0M$-595.0M$114.0M$582.0M$-149.0M
Free Cash Flow$165.0M$472.0M$537.0M$1.4B$1.6B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.26
EV / EBITDA17.75
FCF Yield5.27%
Quick Ratio1.30
Interest Coverage5.13
Return 1Y-7.31%
Return 3Y-2.61%
Return 5Y-17.31%

Ownership

Insiders Held0.17%
Institutions Held66.43%
Institutions Float Held66.55%
Institutional HolderSharesReport Date
Bank Of New York Mellon Corporation15,669,6622026-03-31
Vanguard Capital Management LLC14,871,6072026-03-31
FMR, LLC12,426,9922026-03-31
Aristotle Capital Management, LLC10,584,3742026-03-31
AKO Capital LLP9,324,6562026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLCOBausch + Lomb Corporation $17.47 +0.23% -35.85 $6.24B 0.00%
COOThe Cooper Companies, Inc. $61.21 -0.71% 19.29 $11.64B 0.00%
ESLOYEssilorLuxottica S.A. $98.62 -1.15% 31.71 $90.65B 2.35%
GKOSGlaukos Corporation $178.88 +1.24% -50.38 $10.55B 0.00%
HOCPFHOYA Corporation $159.57 +0.00% 32.45 $53.38B 1.34%

About Alcon Inc.

Alcon Inc. is led by CEO David J. Endicott, employs 25,599 people, headquartered in Geneva, CH, publicly traded since 2019.

Alcon Inc. (ALC) stock trades at $70.17 with a market capitalization of $33.92B. The stock is valued at a price-to-earnings (P/E) ratio of 50.34, price-to-book of 1.47, price-to-sales of 2.95. Over the past 52 weeks the stock has ranged between $61.84 and $87.64, and currently trades 19.9% below its 52-week high. It pays a dividend yielding 0.55%.

On profitability, Alcon Inc. generates a return on equity (ROE) of 2.91%, return on capital employed of 3.82%, an operating margin of 13.08%, a net profit margin of 5.92%.

In its most recent fiscal year, Alcon Inc. reported annual revenue of $10.4B, net profit of $980.0M. Revenue grew at an average annual rate of 8.8% over the last 5 fiscal years.

The balance sheet shows a debt-to-equity ratio of 0.25 (debt below half of shareholders' equity), a current ratio of 2.12, total assets of $31.6B, $1.5B in cash and equivalents.

ALC has an average daily trading volume of 1,869,720 shares, a beta of 0.70 (historically less volatile than the overall market).

Alcon Inc. by the numbers, 2016–2025

Between 2016 and 2025 Alcon Inc. reported revenue of $6.6B rising to $10.4B, a change of +57.7% across 10 years. Compounded, revenue has grown 8.8% a year over five years, 6.1% over three, 4.9% over the last twelve months. Net profit rose to $980.0M.

Operating margin went from 0.1% in 2016 to 13.1% in 2025, a gain of 12.9 percentage points. The most recent net margin is 5.92%. On a trailing twelve-month basis to Jun '26, revenue is $10.7B and net profit $639.0M.

Borrowings rose from $249.0M to $5.2B, cash from operations was $2.3B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 3.5% over five years, and was 4.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Alcon Inc. (ALC) — frequently asked questions

What is Alcon Inc. (ALC) stock price today?

Alcon Inc. (ALC) is currently trading at $70.17, down 0.65% today.

What is ALC P/E ratio?

Alcon Inc.'s P/E ratio is 50.34. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is ALC return on equity (ROE)?

Alcon Inc.'s return on equity (ROE) is 2.91%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Alcon Inc.'s market cap?

Alcon Inc. has a market capitalization of $33.92B.

Does ALC pay a dividend?

Yes. Alcon Inc. currently yields 0.55%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does ALC carry?

Alcon Inc. has a debt-to-equity ratio of 0.25. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is ALC's profit margin?

Alcon Inc. reports a net profit margin of 5.92% — the share of revenue left after every cost, including tax and interest.

What sector is ALC in?

Alcon Inc. is classified under Healthcare, in the Medical - Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is ALC listed on?

Alcon Inc. trades on NYSE under the ticker ALC.

What is ALC's 52-week range?

Over the last year Alcon Inc. has traded between $61.84 and $87.64.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens ALC currently matches

On the figures above, Alcon Inc. passes the filters for 9 of our ready-made screens, among them Low Debt Stocks, Large Cap Stocks, High PE Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt StocksLarge Cap StocksHigh PE StocksStocks Under $100Large Cap Dividend StocksNYSE Listed StocksDebt to Equity Below 1 StocksHigh Current Ratio StocksLow Debt Large Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.